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ABSTRACT
Reverse gyrase is a peculiar DNA topoisomerase,
specific of hyperthermophilic Archaea and Bacteria,
which has the unique ability of introducing positive
supercoiling into DNA molecules. Although the
function of the enzyme has not been established
directly, it has been suggested to be involved in
DNA protection and repair. We show here that the
enzyme is degraded after treatment of Sulfolobus
solfataricus cells with the alkylating agent MMS.
MMS-induced reverse gyrase degradation is highly
specific, since (i) neither hydroxyurea (HU) nor puro-
mycin have a similar effect, and (ii) topoisomerase VI
and two chromatin components are not degraded.
Reverse gyrase degradation does not depend on
protein synthesis. Experiments in vitro show that
direct exposure of cell extracts to MMS does not
induce reverse gyrase degradation; instead, extracts
fromMMS-treatedcellscontainsomefactor(s)ableto
degrade the enzyme in extracts from control cells.
In vitro, degradation is blocked by incubation with
divalent metal chelators, suggesting that reverse
gyrase is selectively degraded by a metal-dependent
protease in MMS-treated cells. In addition, we find a
striking concurrence of extensive genomic DNA
degradation and reverse gyrase loss in MMS-treated
cells. These results support the hypothesis that
reverse gyrase plays an essential role in DNA
thermoprotection and repair in hyperthermophilic
organisms.
INTRODUCTION
Alkylating agents induce extensive damage of DNA, RNA,
lipids and proteins, thus affecting virtually every cell process.
Therefore it is expected that organisms cope with alkylating
damage activating a highly coordinated response to carry out
repair, removal and replacement of damaged molecules (1,2).
Alkylating damage in DNA can be repaired following speciﬁc
mechanisms, such as excision by the base excision repair
(BER) pathway and direct demethylation by DNA methy-
transferases, as well as by other repair pathways, such as
nucleotide excision repair (NER) and homologous recombina-
tion (HR) (3,4). In addition, genetic and expression analysis
showed that the cell response to alkylation damage involves a
high fraction of genes involved in all cell processes (5–8).
Methylating agents are widely occurring in nature in all
environments, including thermophilic niches, as by-products
of biomass decaying and burning (3,9). Archaea, including
those adapted to thermophilic environments, encode for
homologs of eukaryal enzymes involved in NER, BER and
HR (10); several of them have been characterized biochemi-
cally and structurally [reviewed in (11,12)]. However, the
effects of methylating agents have been studied in none of
the Archaea or thermophilic organisms.
Reverse gyrase is a peculiar enzyme found only in hyper-
thermophilic microorganisms, which induces positive super-
coiling in an ATP-dependent reaction. The enzyme has a
modular organization, with a N-terminal domain showing
the signature of Superfamily II helicases, and a C-terminal
topoisomerase domain. This latter belongs to the Topo IA
family of DNA topoisomerases, ubiquitous in Bacteria and
Eucarya. Whereas the C-terminaldomain isable toperform an
ATP-independent DNA relaxation reaction, neither the whole
protein nor the isolated N-terminal domain shows helicase
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doi:10.1093/nar/gkl115activity (13–16). In the hyperthermophilic archaeon
Sulfolobus solfataricus, reverse gyrase activity is negatively
regulated by one of the main chromatin components of this
strain, Sul7d (17), whereas it is stimulated by the single strand
binding protein SSB (18).
Because reverse gyrase is the only hyperthermophile-
speciﬁc protein identiﬁed so far (19), and positive supercoiling
is known to stabilize DNA, the enzyme has been associated to
adaptation to high temperature. Recently, reverse gyrase was
reported to have ‘DNA chaperone’ activity in vitro, preventing
heat-induced breakage and aggregation of the double strand
(20). Genetic analysis in Thermococcus kodakaraensis
showed that a strain disrupted for reverse gyrase gene was
viable, but its growth was signiﬁcantly retarded speciﬁcally at
high temperature, and suggested that the enzyme plays a role
in maintenance of genome stability (21).
We have previously shown that reverse gyrase is recruited
to DNA in S.solfataricus after ultraviolet (UV) irradiation
(22), suggesting that the enzyme is involved, directly or
indirectly, in the cell response to DNA damage.
We therefore sought to investigate the effect of other
damaging agents on reverse gyrase. We show here that the
enzyme is speciﬁcally depleted from cells treated with the
alkylating agent MMS. This phenomenon is highly selective,
since none of the other proteins tested (Topoisomerase VI, the
two non-speciﬁc DNA binding proteins Sul7d and Smj12, and
one subunit of the chaperone prefoldin) showed reduction of
their amount. Likewise, the replication inhibitor hydroxyurea
(HU) did not induce reverse gyrase loss. Depletion of reverse
gyrase from MMS-treated extracts is not due to transcriptional
down-regulation, as shown by quantitative RT–PCR, and
occurs in the absence of protein synthesis. Experiments
in vitro shows that reverse gyrase depletion is not induced
by direct exposure of cell extracts to MMS; however, extracts
fromMMS-treatedcells contain some factor(s) abletodegrade
the enzyme in extracts from control cells. This degradation is
blocked by the presence of divalent metal chelators [EDTA or
1,10 phenantroline (PHE)], strongly suggesting that reverse
gyrase is selectively degraded by a metal-dependent protease
activated in MMS-treated cells. In addition, we show that
genomic DNA is extensively degraded after MMS treatment,
and we found striking coincidence between timing and dose-
dependence of DNA and reverse gyrase degradation. Our
results are discussed in light of the potential protective role
of reverse gyrase against damage to DNA.
MATERIALS AND METHODS
Cultures growth, treatment and extract preparation
S.solfataricus P2 cultures were grown at 80 C as described
previously (23) until exponential phase (about 0.4 OD600);
compounds were added to an aliquot of the culture, and the
rest was used as a control. Incubation continued for different
duration at 80 C. Aliquots of treated and control cultures were
withdrawn and used for preparation of total and fractionated
protein extracts as described (22).
Western blot
Total and fractionated extracts were analysed using the
Amersham ECLPlus kit and a ChemiDoc apparatus (BioRad).
Polyclonal antibodies against Sulfolobus acidocaldarius
reverse gyrase (24), S.solfataricus Sul7d (25), topoisomerase
VI B subunit (P. Forterre and M. Gadelle, Orsay, unpublished
data) and the b-subunit of prefoldin (A. D’Amaro and
M. Ciaramella, unpublished data) were raised in rabbit, and
against S.solfataricus Smj12 (25) was raised in goat.
Reverse gyrase assays
Reverse gyrase activity was assayed in total protein extracts
and quantiﬁed as reported (18,22). Plasmid pGEM7 was from
Promega. For quantiﬁcations, the ﬂuorescence of each band in
ethidium bromide-stained gels was measured under UV light
with a Chemidoc apparatus and the QuantityOne software
(BioRad). The speciﬁc linking difference (s) was determined
using the equation s ¼ DLk/Lk0. s values of the topoisomers
whose intensity was >30% of the intensity of the most intense
topoisomer were considered for the calculation of the mean s
value.
Real-time RT–PCR
Total RNA was prepared as previously described (23), exten-
sively digested with DNAse (Qiagen) and the absence of DNA
was assessed by the lack of PCR ampliﬁcation with each sets
of primers described below. Total cDNA was obtained using
M-MLV Reverse Transcriptase and random hexamers
(Ambion). cDNA was then ampliﬁed in a BioRad LightCycler
using the DyNAmo HS Syber Green qPCR Kit (Finnzymes).
Oligonucleotides used for ampliﬁcation were the following:
GACCCTTGCCACCATACACT; TCCCCTTGTTCTATG-
GATGC for TopR1; CTGCCATGTGAGGCTTGTTTAC;
CTCTGATTACTCGCAAGCCTTC for TopR2; GAATG-
GGGGTGATACTGTCG; TTTACAGCCGGGACTACAGG
for the 16S rRNA gene. Optimal melting temperatures for
each primer pair were determined by performing real-time
analysis with a temperature gradient ranging over 10 C; nega-
tive controls with no template cDNA were always included.
PCR conditions were: 15 min at 95 C for initial denaturation,
followed by 40 cycles of 10 s at 95 C, 25 s at 56 C and 35 s at
72 C, and a ﬁnal step of 10 min at 72 C. Product purity was
controlled by melting point analysis of setpoints with 0.5 C
temperature increase from 72  to 95 C. PCR products were
analysed on 2% agarose gels and visualized by ethidium
bromide staining.
The expression values of reverse gyrase genes were
normalized to the values determined for the 16S rRNA
gene. Absolute expression levels were calculated as Target/
16S ratio in controls and MMS-treated cells, respectively.
Relative mRNA expression levels (controls/MMS-treated
cells ratio) were calculated as (Target/16S ratio in MMS-
treated cells)/(Target/16S ratio in controls). Data reported
are from two independent RNA preparations; each cDNA
was then used for two independent ampliﬁcations and in
each ampliﬁcation samples were in triplicate.
Preparation and analysis of genomic DNA
A protocol was set up for the extraction of total DNA without
bias for high-molecular weight molecules, in order to extract
with similar efﬁciency long as well as degraded DNA
fragments. Cultures grown as described above (80 ml) were
centrifuged and the cell pellet was resuspended in 0.3 ml of
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The lysate was extracted ﬁve times with a phenol–
chlorophorm (1:1) suspension equilibrated in 10 mM
Tris–HCl (pH 8), 1 mM EDTA. Nucleic acids were then
ethanol precipitated and RNA was digested by RNAse A
(1 mg/ml). DNA was analysed by electrophoresis in 1% agar-
ose gel in Tris–Acetate buffer containing 1 mg/ml ethidium
bromide. Gels were photographed under UV light using the
Chemidoc system (BioRad).
RESULTS
S.solfataricus is highly sensitive to MMS
S.solfataricus P2 cultures were grown at 80 C in rich medium
with shaking; under these conditions, the replication cycle of
this strain is about 7 h and it takes about 24 h from dilution to
reach the exponential phase. Different concentrations of MMS
were added and culture density was followed spectrophoto-
metrically (Figure 1A). Whereas the drug at 0.17 mM only had
a minor effect, all higher MMS concentrations induced slight
reduction of absorbance. After 24 h, absorbance resumed
exponential increase if 0.35 mM was used; in contrast,
at higher MMS concentrations culture density remained essen-
tially constant over the next 48 h. Absorbance was also
measured 2 and 6 h after MMS addition, showing values
similar to controls at 0.17 mM MMS; instead, when 0.35,
0.7 and 1.4 mM MMS were used, the cell density remained
essentially similar to that measured at the time of MMS
addition (data not shown).
The same results were obtained if after 30 min of incubation
with MMS at different concentrations, the cultures were
centrifuged and fresh medium was added (data not shown).
These data demonstrate that S.solfataricus is remarkably more
sensitive to MMS than mesophilic model organisms: for
instance, wild-type Escherichia coli strains are fully resistant
to 1.5 mM and Saccharomyces cerevisiae to 5 mM MMS
(26,27).
Phase-contrast microscopy showed that, consistent with OD
reduction, the total cell number was highly reduced 24 h after
treatment with 0.35–1.4 mM MMS. In addition, MMS-treated
cells show heterogeneous aspect, with most cells of
reduced size with respect to controls and several larger
cells with disordered interior that might be indicative of
problems in DNA replication and cell division (data not
shown).
Total protein content from controls and MMS-treated
cultures was analysed by SDS gel electrophoresis. No
dramatic change in the protein pattern was apparent under
the conditions used (Figure 1B).
MMS treatment induces reverse gyrase loss
We have previously shown that reverse gyrase is translocated
from the cytoplasm to DNA in S.solfataricus after UV
irradiation (22). We therefore wondered whether MMS also
affected reverse gyrase level or distribution. Cultures grown at
80 C were treated with different amounts of MMS, cells were
lysed after 2 h and lysates were fractionated, obtaining a
soluble supernatant and a pellet containing genomic
DNA with tightly associated chromosomal proteins (22).
We analysed the amount and distribution of reverse gyrase
in cell extracts by western blotting using a polyclonal antibody
directed against the S.acidocaldarius reverse gyrase which
recognizes the S.solfataricus protein (Figure 2A).
As shown previously (22), under the experimental condi-
tions used to prepare these extracts, in control cells about 90%
of reverse gyrase was found in the soluble fraction, and only
about 10% in the pellet. A similar distribution was observed at
0.35 mM (Figure 2A) or lower MMS concentrations (data not
shown). In contrast, 2 h after MMS treatment the protein was
dramatically reduced in supernatants at 0.7 mM MMS and
disappeared at 1.4 mM MMS; only a slight reduction was
observed in the pellets. The same ﬁlter was probed with an
antibody directed against the B subunit of topoisomerase VI,
an archaeal-speciﬁc type II topoisomerase (28): topoisomerase
VI was mainly associated to the insoluble fraction, and no
variations in its level or distribution were observed after
MMS treatment. As a control of loading we also used an
antibody directed against the b-subunit of the chaperone
prefoldin, which showed no signiﬁcant variations (Figure 2A).
Reverse gyrase depletion was both time- and MMS
concentration-dependent: indeed, after 30 min of treatment,
Figure 1. Effects of MMS treatment on S.solfataricus.( A) S.solfataricus P2
culturesweregrownat80 Cuntiltheexponentialphase;atthetimeindicatedby
the arrow, cultures were split and MMS was added to each aliquot at
the indicated concentrations; one aliquot was mock-treated. Absorbance at
600 nm was measured at indicated time points. Values from five independent
experiments are reported. (B) Coomassie-stained SDS–PAGE of total proteins
(60 mg/lane) extracted 2 h after treatment with indicated MMS concentrations.
Lane 1, molecular weight marker (kDa).
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respectively, if 0.7 or 1 mM MMS was used (Figure 2B).
Although no reduction of reverse gyrase content was
observed after 2 h of treatment with 0.35 mM MMS, the
level of the enzyme was transiently reduced after 6 h and
returned to normal levels 24 h after MMS addition
(Figure 2C).
Reverse gyrase activity in cell extracts is reduced upon
MMS treatment
We next sought to determine whether the residual reverse
gyrase persisting at lower MMS concentrations was active.
The positive supercoiling activity of reverse gyrase can be
assayedby2Dgel electrophoresis.IncubationofS.solfataricus
cell extracts with a negatively supercoiled plasmid in the
presence of ATP results in production of topoisomers with
increasing linking number. We measured reverse gyrase
activity in extracts from cultures treated with different
MMS concentrations (Figure 3). The activity was similar to
that found in the control at 0.35 mM MMS and it was greatly
reduced at 0.7 mM. At 1 mM MMS a weak relaxing activity
was present in cell extracts, but no positive topoisomers were
produced. Thus the enzyme activity correlates well with its
amount, providing no evidence of enzyme inactivation.
Effect of MMS on other proteins affecting DNA
structure
To obtain a more general picture of changes in chromatin
composition associated with alkylating DNA damage, we
analysed the effect of MMS on two DNA binding proteins
involved in the control of DNA structure in S.solfataricus,
namely Sul7d and Smj12. Sul7d (formerly called Sso7d) is
a 7 kDa architectural protein, speciﬁc of the Sulfolobus genus
and is one of the main chromatin components in these strains.
This protein induces DNA bending, compaction and negative
supercoiling, (17) and it negatively regulates reverse gyrase
activity (17,18). Smj12 is a member of a large family of helix–
turn–helix DNA binding proteins found in Archaea and
Bacteria that binds DNA non-speciﬁcally and induces positive
supercoilingincooperationwithtopoisomerases (25).Ithasno
effect on reverse gyrase activity (18).
The total amount of these proteins did not change after
exposure to MMS (Figure 4A). However, interestingly, both
Sul7d and Smj12 showed signiﬁcant changes in their distri-
bution after MMS treatment. In control cells, both proteins
were mainly associated to the chromatin fraction; however, at
both MMS concentration tested, a signiﬁcant, MMS
concentration-dependent amount of both proteins was translo-
cated to the soluble fraction, showing a parallel reduction in
the chromatin fraction.
The mechanism and biological meaning of the translocation
of two binding proteins affecting DNA conformation from
DNA to the cytosol fraction are currently under study. For
the purpose of this work, the results reported in this paragraph
conﬁrm that reverse gyrase loss is a speciﬁc event and does not
concern DNA-interacting proteins in general.
HU does not induce reverse gyrase loss
The effect of MMS on reverse gyrase is very different from
that seen with UV radiation that induces translocation of the
enzyme to DNA but not changes in the overall protein level. In
addition, we have previously shown that actynomycin D, a
transcription inhibitor which blocks DNA topoisomerases and
elicits a transcriptional response similar to that induced by UV
(23), does not induce any change in reverse gyrase level or
distribution (22).
We therefore checked the effect of other agents blocking
cell growth with different mechanisms, namely HU and
puromycin (see below). HU is a ribonucleotide reductase
inhibitor, known to induce a replication block in both bacteria
and eukaryotes by reducing the deoxynucleotide pool. Its
effect in Archaea has not been reported so far. Treatment
of S.solfataricus cultures with 10 mM HU induced a block
of absorbance increase (Figure 4B). Phase-contrast
microscopy of HU-treated cultures showed reduction of
cell number and heterogeneous phenotypes similar to
that observed with high MMS concentrations (data not
shown).
However, no variation of reverse gyrase levelor distribution
was observed after 2 h of treatment with the same HU
concentration (Figure 4C). In addition, HU did not affect
signiﬁcantly the level and distribution of Sul7d, Smj12 or
TopoVI. Taken together with previous results and those
obtained with puromycin reported in the next paragraph,
this ﬁnding shows that reverse gyrase loss is highly speciﬁc
Figure 2. MMS treatment induces reverse gyrase loss. (A) Western blot of
soluble and insoluble protein extracts (200 mg/lane) prepared from cultures
treated with MMS at the indicated concentrations. Extracts were prepared 2 h
after MMS or mock treatment. The same filter was stripped and probed with
antibodies against the indicated proteins. (B and C) Reverse gyrase level in
soluble extracts (200 mg/lane) prepared from controls and cultures treated with
theindicatedMMSconcentrations(mM)attheindicatedtimepoints.Thesame
filters were stripped and probed with the anti b-prefoldin antibody.
Nucleic Acids Research, 2006, Vol. 34, No. 7 2101for MMS and is not a consequence of replication block and/or
cell death in general.
Reverse gyrase loss is a post-translational event
To check whether reverse gyrase disappearance in
MMS-treated cells depends on transcriptional down-
regulation, we analysed the level of the reverse gyrase
mRNA by quantitative RT–PCR. Reverse gyrase is encoded
by two genes in S.solfataricus P2 (29). We therefore designed
a set of speciﬁc primers for each gene and performed
quantitative real-time RT–PCR on cDNA prepared from
RNA extracted after 2 h of treatment with different MMS
concentrations. The mRNA for both TopR1 and TopR2 was
present and even slightly increased in MMS-treated with
respect to control cells (Figure 5A), thus showing that reverse
gyrase disappearance is not due to transcriptional silencing.
We then checked whether reverse gyrase disappearance
after MMS treatment requires active protein synthesis. To
this aim we used puromycin, an antibiotic that interferes
with protein synthesis and blocks DNA replication in the
hyperthermohilic archaeon Pyrococcus abyssi (30). Treatment
with 50 mg/ml of puromycin induced a block of culture density
increase (Figure 5B). Cell cultures were pre-treated with pur-
omycin for 30’, then MMS at 1 mM was added and proteins
were extracted after 2 h of incubation at 80 C (Figure 5C).
Figure 3. Reverse gyrase activity in cell extracts after MMS treatment. (A) 2D gel showing the migration of the substrate, pGEM7 plasmid DNA; arrows indicate
the position of the nicked and negatively supercoiled( SC) plasmid forms. (B) Positive supercoiling activity in soluble cell extracts prepared from cultures treated
with MMS at the indicated concentrations. Extracts were prepared 2 h after MMS or mock treatment. Each sample contained 5 mg of protein (final concentration
0.25mg/ml).Negativeandpositivetopoisomersmigrateattheleftandrightpartofthearc,respectively.Representativegeloutofthreeindependentassaysisshown.
(C) Quantification of reverse gyrase activity; the mean specific linking difference (mean s) was calculated as described in Materials and Methods. Values are the
mean of three independent experiments.
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amount was reduced to about 60% of the control. From this
result we could draw two conclusions: (i) puromycin did not
induce complete reverse gyrase loss, emphasizing again the
speciﬁcity of MMS action; (ii) the reverse gyrase half life is
about 2 h, thus the enzyme disappearance in MMS-treated
cells is not simply a consequence of the physiological protein
turnover in the absence of protein synthesis, but rather is the
result of an active degradation.
When MMS was added to cells pre-treated with puromycin,
reverse gyrase was almost completely absent after 2 h of
incubation, as in cells treated with MMS without puromycin
(Figure 5C). This result shows that degradation of reverse
gyrase in MMS-treated cells does not depend on
MMS-induced synthesis of a protein factor.
Reverse gyrase is degraded by a metal-dependent
protease
Twopossibilities canbesuggestedtoexplain the resultsshown
so far: either exposure to MMS induces some modiﬁcation in
reverse gyrase that renders the enzyme prone to degradation,
Figure 4. (A) Chromatin proteins are not depleted after MMS treatment. Western blot of total, soluble and insoluble protein extracts (200 mg/lane) prepared from
cultures treated with MMS at the indicated concentrations. Extracts were prepared 2 h after MMS or mock treatment. The same filter was stripped and probed with
antibodies against the indicated proteins. (B) S.solfataricus P2 cultures were grown at 80 C until the exponential phase; at the time indicated by the arrow, cultures
were split and 10 mM HU was added to one aliquot; absorbance at 600 nm was measured at indicated time points. (C) Western blot of total (T), soluble (S) and
insoluble (I) protein extracts (200 mg/lane) prepared from cultures treated with 10 mM HU. Extracts were prepared 2 h after HU or mock treatment. The same filter
was stripped and probed with antibodies against the indicated proteins.
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tion of the enzyme. To distinguish between these possibilities,
we attempted to mimic reverse gyrase degradation in vitro,b y
adding 1 mM MMS to cell extracts prepared form control cells
and analysing the residual reverse gyrase amount after incuba-
tion at 80 C (Figure 6A). No variation of reverse gyrase level
was observed, suggesting that its degradation is not a direct
effect of some MMS-induced chemical modiﬁcation (e.g.
methylation).
We then mixed extracts from control cells, containing
reverse gyrase, with equal amounts of extracts from cells
treated with 1 mM MMS for 1 h, which contain very low
levels of the enzyme. The mix was incubated for 30 min at
70 C and analysed by western blotting (Figure 6B). Reverse
gyrase content in the extract mix was signiﬁcantly reduced,
thus showing that extracts from MMS-treated cells contain
some factor(s) able to induce partial degradation of the
enzyme in extracts from control cells. Degradation was
also observed if extracts prepared after 30 min or 2 h from
MMS addition, and drug concentrations between 0.7 and
1.4 mM were used (data not shown). Degradation was pre-
vented by incubating the extract mix with EDTA or 1,10 PHE,
but not phenylmethlysulfonyl ﬂuoride (PMSF). In addition,
degradation was not blocked if we added to the mix
excess of puriﬁed plasmid DNA, either untreated or pre-
treated with MMS (Figure 6C). Together, these results
show that MMS-induced selective reverse gyrase degradation
Figure 5. (A)Reversegyraselossisapost-translationalevent.RelativemRNA
levels for TopR1 and TopR2 in cells treated with the indicated MMS concen-
trations (mM) were determined using real-time RT–PCR. Total RNA was
extracted after 2 h of treatment. Data were normalized to the expression level
of 16S rRNA and expressed as the relative mRNA level compared with the
average expression level in control cells. (B) S.solfataricus P2 cultures were
grown at 80 C until the exponential phase; at the time indicated by the arrow,
cultures were split and 50 mg/ml of puromycin was added to one aliquot at the
time pointindicatedbythe arrow.After30 min,controland puromycin-treated
aliquotsweresplitagainand1mMMMSwasaddedtoonehalfofeachaliquot.
Absorbance at 600 nm was measured at the indicated time points. (C) Western
blot of soluble protein extracts (200 mg/lane) prepared from cultures treated
withindicateddrugs.Lane1,extractsfromcontrolsbeforepuromycinaddition;
lane2,extractsfromcontrolsafter2.5hofmocktreatment;lane3,extractsfrom
cultures treated with puromycin for 2.5 h; lane 4, extracts from cultures treated
with 1 mM MMS for 2 h; lane 5, extracts from cultures treated with puromycin
for 30 min followed by 1 mM MMS for 2 h. The same filter was probed with
antibodies against the indicated proteins.
Figure 6. Reverse gyrase is degraded by a metal-dependent protease.
(A) Soluble protein extracts (200 mg/lane) prepared form control cells were
incubated at 80 C with 0 (lane 1) or 1 mM MMS for 15 min (lane 2) or 30 min
(lane 3) and reverse gyrase amount was analysed by western blotting. (B)
Extracts form control cells (200 mg/lane) and extracts from cultures treated
with1mMMMSfor2h(200mg/lane),aloneormixed,wereincubatedat70 C
for30min.Lane1,extractfromcontrolcells;lane2,extractfromcontrolcells+
extractfromMMS-treatedcells;lane3,aslane2with10mM1,10PHE;lane4,
as lane 2 with 4 mM PMSF; lane 5, as lane 2 but with 5 mM EDTA; lane 6,
extracts from MMS-treated cells. The residual reverse gyrase content was
analysed by western blotting. (C) Extracts form control cells (200 mg/lane)
and extracts from cultures treated with 1 mM MMS for 2 h (200 mg/lane) were
mixed and incubated at 70 C for for 30 min with or without pGEM7 plasmid
DNA(Promega).Lane1,extractfromcontrolcells;lane2,extractfromcontrol
cells+extractfromMMS-treatedcells;lane3,aslane2with500ngofuntreated
pGEM7plasmidDNA;lane4,aslane2with500ngofplasmidDNApre-treated
for 15 min with 1 mM MMS.
2104 Nucleic Acids Research, 2006, Vol. 34, No. 7requires some factor present in MMS-treated cells, that a
metal-dependent protease is involved in this degradation
and DNA does not protect the enzyme. MMS might induce
post-translational activation of an endogenous protease that
selectively cleaves reverse gyrase. Alternatively, MMS might
activate pre-existing factor(s) that trigger(s) some reverse
gyrase modiﬁcation turning the enzyme into a protease-
sensitive form.
MMS induces extensive DNA degradation
MMS generates primarily methylation of guanine in position
N7 and, at lesser extent, O-6 methylguanine and N-3 methy-
ladenine adducts; alkylated bases are heat labile and may give
rise to strand breaks if incubated above 50 C (31).
To monitor the effect of MMS treatment on genomic DNA,
S.solfataricus cultures were treated with different MMS
concentrations, aliquots were harvested after various times,
total DNA was puriﬁed and analysed by agarose gel electro-
phoresis. No genomic DNA degradation was observed in
controls or in cells treated for 2 h with 0.35 mM MMS. In
contrast, in cells treated with higher MMS concentrations for
2 h, DNA was extensively degraded in a concentration-
dependent manner (Figure 7A and B). When 1.4 mM MMS
was used, DNA degradation was evident after 30 min and
almost complete after 2 h of MMS treatment (Figure 7B).
After 24 h from treatment DNA was completely degraded
(data not shown). Degradation was also detectable, at a lesser
extent, 30 min after addition of 0.7 or 1.0 mM MMS (data not
shown). DNA extracted from the soluble and insoluble
fractions of controls and MMS-treated cells showed a pattern
similar to that observed for total DNA, even if its amount was
unequally distributed, with more than 99% in the pellets and
only minor contamination in the supernatants (data not
shown).
Although DNA was intact after 2 h of treatment with
0.35 mM MMS, it was slightly degraded after 6 h (Figure 7C);
however, degradation was greatly reduced 24 h after MMS
addition.
Genomic DNA degradation observed in S.solfataricus
might be a consequence of methylation of DNA bases during
growth at 80 C. Indeed incubation with 1 mM MMS for
30 min at 80 C of DNA puriﬁed from untreated cells resulted
in extensive degradation (data not shown). Interestingly, there
is striking coincidence in both timing and extent of
DNA and reverse gyrase degradation after MMS treatment
(see Discussion).
DISCUSSION
The major conclusion of this work is that MMS induces two
dramatic events in S.solfataricus: (i) speciﬁc degradation of
reverse gyrase and (ii) concomitant genomic DNA degrada-
tion. Although at present we cannot establish a causal rela-
tionship between these two events, it is tempting to speculate
that they are in some way connected. DNA and reverse gyrase
are degraded at the same MMS concentrations and with over-
lapping timing; both reverse gyrase and DNA are extensively
degraded whenever growth is irreversibly arrested (MMS con-
centrationsabove 0.35mM).At0.35mM MMSdegradation of
both DNA and reverse gyrase is partial and transient, and
occurs in parallel with the transient growth arrest; when
normal growth resumes reverse gyrase content returns to
normal levels and DNA is not fragmented.
Kampmann and Stock (20) reported that reverse gyrase of
Archaeoglobus fulgidus protects DNA from thermodegrada-
tion in vitro. They suggested a model in which reverse gyrase
might protect DNA by stabilizing apurinic sites, and/or pro-
tecting DNA ends from thermodegradation. Our results
in vivo, although do not directly prove, support and extend
this model: indeed at high temperature alkylated bases give
rise with high frequency to abasic sites, that are easily con-
verted to single strand or double strand breaks and might
trigger DNA denaturation. Reverse gyrase might counteract
degradation at low MMS concentrations; however, at higher
MMS concentrations the enzyme is degraded and DNA is no
longer protected from the combined effects of MMS and heat.
This model predicts that the enzyme should be recruited to
DNA at low MMS concentrations, as seen with UV irradiation
(22); however, this is not the case (Figure 2A). One explana-
tion of this result is that, under the experimental conditions
used, the enzyme can be found associated with DNA only if it
is trapped in covalent intermediates or otherwise very stable
complexes. For some reason these complexes might be formed
with substrates containing large helix-distorting UV-induced
lesions, but not abasic sites.
In an alternative model, reverse gyrase might be degraded to
allow DNA relaxation and exposure of single strand regions
required for access of repair/replication complexes. However,
two observations might argue against this model: (i) reverse
gyrase is not degraded in the case of UV damage (22); (ii)
reverse gyrase is degraded only at higher MMS concentra-
tions, when cells are committed to die, and not at lower
MMS concentrations, when they resume from the damage.
We thus favour a model in which reverse gyrase has a positive,
rather than negative, role in the cell response to MMS-induced
(and possibly other types, of) DNA damage.
In any case, heat-induced conversion of unrepaired alkyla-
tion lesions into DNA breaks may comprise one of the reasons
for the high MMS-mediated cytotoxicity in S.solfataricus.
Our observations raise a number of questions that remain to
be addressed. First of all, which is the signal for reverse gyrase
degradation in MMS-treated cells? We have provided evi-
dence that degradation depends on a metal-dependent protease
yet to be identiﬁed. Since proteins are substrates for MMS
alkylation, reverse gyrase might be alkylated by MMS and
then targeted fordegradation. The removal ofchemicallydam-
aged proteins seems logical to promote recovery from protein
damage. However, we have shown that reverse gyrase is not
degraded if extracts are directly exposed to MMS and, con-
versely, extracts from MMS-treated cells induce degradation
of the enzyme in control extracts in the absence of MMS. We
conclude that (i) alkylation is not the reason for reverse gyrase
degradation, and (ii) degradation requires the activation of
some pathway in vivo. Additionally, we reasoned that if
reverse gyrase is alkylated, it is likely that such modiﬁcation
would alter the enzyme activity besides its stability. However,
we could not detect signiﬁcant change in enzyme speciﬁc
activity in MMS-treated cells compared to controls, thus
providing no evidence of (partial) enzyme inactivation.
If the enzyme is a target for MMS-induced alkylation remains
to be established.
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cycle or replication arrest per se, since HU, puromycin (this
work), UV and actynomycin D (22) all fail to induce reverse
gyrase degradation. Furthermore, this phenomenon is highly
speciﬁc as it does not concern any of the other proteins tested,
including Topo VI and several DNA binding proteins (this
work and data not shown). However, we cannot rule out
the possibility that other proteins may be speciﬁcally affected
by MMS treatment.
No intermediate degradation products of reverse gyrase
were observed even at early stage after MMS addition.
Different hypothesis might explain this result: inter-
mediates might be very unstable and do not accumulate;
proteolysis might give rise to products that are no longer
recognized by the antibody or of very low molecular weight
(<6 kDa). At moment we cannot distinguish among these
possibilities; the isolation of the protease involved in this
process will shed light on the mechanism of reverse gyrase
degradation.
Although the majority of reverse gyrase is found in the
soluble fraction of cell extracts, whereas only a small amount
is associated with the insoluble fraction, the ﬁrst one was
Figure 7. MMSinducesdegradationofgenomicDNA.(A)CulturesweregrownasinFigure1,MMSwasaddedattheindicatedconcentrations(mM)andgenomic
DNAwasextractedafter2hofincubationat80 C.Sampleswererunon1%agarosegelsinTris–Acetatebuffer.Lane1,molecularweightmarker(kb).(B)Cultures
weretreatedwith1.4mMMMSandDNAwasextractedafterindicatedtimespansofincubationat80 C.(C)Culturesweretreatedwith0.35mMMMSandDNAwas
extracted after 6 or 24 h of incubation at 80 C.
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hypotheses could explain this observation: DNA-bound
reverse gyrase might be inherently resistant to degradation,
or the MMS-trigged factor responsible for reverse gyrase
degradation could not access the enzyme in the ‘nucleoidal’
compartment. The addition of puriﬁed DNA failed to protect
reverse gyrase from MMS-induced degradation in vitro
(Figure 6C), thus arguing against a protective effect of
DNA on the enzyme. On the other hand, it is not clear
which is the difference between the soluble and the insoluble
reverse gyrase fractions. For instance, the latter could be
trapped in a covalent intermediate with DNA and this complex
might be resistant to degradation.
The selective degradation of proteins involved in DNA
repair after induction of DNA damage and/or cell cycle arrest
has been reported in other cases, although not in Archaea.I n
human cells MMS activates a cellular protease to degrade the
DNA methyltransferase DNMT1 (32), and EXO1b, a human
mismatch repair-associated exonuclease, is signiﬁcantly
reduced upon treatment of cells with agents that cause rep-
lication fork arrest (33). In addition, Rad51 recombinase, the
mismatch repair protein MLH1 and the Bloom syndrome
helicase (BLM) are all cleaved by caspases following different
apoptotic stimuli (34–37). The biological meaning of these
events is not understood; it has been suggested that some
protein complexes that can repair DNA need to be dismantled
for apoptosis to proceed (34).
BLM is a RecQ family helicase that interacts with
Topoisomerase III; such interaction, which is conserved
from bacteria to humans, is essential for cellular processes,
such as processing of DNA after exposure of cells to DNA
damaging agents (38,39). Interestingly, proteolytic cleavage
of BLM during apoptosis inhibits its interaction with
Topoisomerase III, but the resulting protein is still active as
helicase (37). This ﬁnding suggests that the BLM–TopoIII
complex, rather than the BLM protein itself, is a relevant
player in the apoptotic process.
The analogies between reverse gyrase and RecQ–TopoIII
complexes are manifold. Reverse gyrase comprises a helicase-
like and a topoisomerase IA module; it performes an
SSB-stimulated positive supercoiling reaction (18); it is
recruited to DNA after UV irradiation (22) and is degraded
after induction of cell death by MMS (this work). The
RecQ–TopIII complex of E.coli is able to perform strand
passage inducing negative supercoiling (40,41); this reaction
isstimulated by single strand bindingproteins. Membersofthe
RecQ family localize to speciﬁc nuclear foci after induction of
DNA damage in yeast and mammals (42,43); BLM is cleaved
during apoptosis (36,37). It is tempting to speculate that
reverse gyrase degradation has some role analogous to
BLM proteolysis.
It is well known that induction of apoptosis in higher
eukaryotes is characterized by two landmarks: DNA
fragmentation and activation of proteases. The activation of
speciﬁc proteases induced by DNA damage, cell cycle arrest
or death signals has never been reported in Archaea, nor are
homologs of eukaryotic caspases present in their genomes.
It would be of outstanding interest to identify the protease
responsible for reverse gyrase degradation and its function
in the biology of S.solfataricus.
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